Skip to main content
# العنوان المشارك في البحث سنة البحث
11 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters إسراء مصطفى كمال محمد 2025
12 Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients إسراء مصطفى كمال محمد 2025
13 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer د. عادل جمعه محمد جبر 2024
14 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line د. آمن حمدى زكى على 2024
15 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer هدير محمد سعد الشاذلي 2024
16 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line أ.د.أشرف زيدان عبدالله أحمد 2024
17 Assessment of Response to Hormonal Therapy by Serum Ki-67 as a Biomarker in Non-metastatic Hormone Positive Breast Cancer زينه عمر عطيه سيد 2024
18 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer د. أسماء محمد زهران عمر 2024
19 The transcription factor ZEB-1 conveys chemoresistance in breast cancer سمر ابوطالب محمود عمر 2024
20 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer د. آمن حمدى زكى على 2024